Last reviewed 2026-04-23 · How we verify

Ice T

Ice T is an anesthetic and analgesic agent.

Ice T is an anesthetic and analgesic agent. Used for Local anesthesia for minor surgical procedures.

At a glance

Mechanism of action

It works by blocking nerve impulses, thereby reducing pain and discomfort. Ice T is often used in medical settings to provide temporary pain relief.

Approved indications

• Local anesthesia for minor surgical procedures

Common side effects

• Numbness
• Tingling
• Allergic reactions

Key clinical trials

• Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma (PHASE3)
• A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma (PHASE2, PHASE3)
• Research on Intraoperative Hypothermia Risk Prediction Model and Temperature Management Strategy for Elderly Patients During Surgery Based on Dynamic Incremental Training (NA)
• Mosunetuzumab in Combination With Platinum-Based Salvage Chemotherapy in Patients With Relapsed/Refractory Aggressive B Cell Lymphoma (PHASE1)
• A Study of Evaluating the Safety and Efficacy of ATG-010 Combined With Chemotherapy Sequential With ATG-010 Monotherapy Maintenance in Peripheral T- and NK/T-cell Lymphoma (PHASE1, PHASE2)
• Why Wait? Initiating Contingency Management in Traumatically Injured Patients During Hospitalization (NA)
• A Study Evaluating the Efficacy, Safety, and Pharmacokinetics of Glofitamab in Combination With Rituximab Plus Ifosfamide, Carboplatin Etoposide Phosphate in Participants With Relapsed/Refractory Transplant or CAR-T Therapy Eligible Diffuse B-Cell Lymphoma (PHASE1)
• Study of Effectiveness of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.